The effect of oral Tranexamic Acid for bleeding in Spinal Surgery. Hemorrhagic condition, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients aged 18 to 60 years who are candidates for spinal surgery for any cause other than trauma, will be used on the day before surgery and 500 mg on the morning
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: being in a range of ages 18 to 60 lack of cardiovascular disease Patients undergoing lumbar and back spine surgery, including discopathies with spinal fusion, and discopathies more than two levels or two-sided spinal cord.
Exclusion criteria
Exclusion criteria: unwillingness to participate in the study abnormal bleeding platelet count less than 150,000 (k) a history of thrombosis or embolism severe allergies using drugs that interact with hemostasis in the blood high and uncontrolled blood pressure (blood pressure mre than 160/90) obese people (body mass index more than 30).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of Bleeding after Oral Administration of Tranexamic acid. Timepoint: Before and after intervention will measure. Method of measurement: The amount of blood collected in cc. | — |
Secondary
| Measure | Time frame |
|---|---|
| The coagulation tests. Timepoint: Will be checked during and 72 hours after the operation. Method of measurement: According to standard one-stage APTT method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNour Mohammad Mamizadeh
Ahvaz University of Medical Sciences
Outcome results
None listed